$BCRX BIOCRYST PHARMACEUTICALS INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in BIOCRYST PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in BIOCRYST PHARMACEUTICALS INC for free.

CIK Number: 0000882796
IRS Number: 621413174
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: BCRX
Company Address: 4505 EMPEROR BOULEVARD SUITE 200 DURHAM 27703

BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC.

Market Capitalization: $427.06M
Prev close: $5.67
Average Daily Volume: 981,787
Days Low: $5.55
Year Low: $1.63
Year High: $7.56

BIOCRYST PHARMACEUTICALS INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
ASELAGE STEVEDirector25,092142,272shares bought: 25,092 / shares sold: 0 STRONG BUYMay 14 20202 months ago
Doyle AnthonyChief Financial Officer00May 04 20202 months ago
HEGGIE THERESADirector11,20463,527shares bought: 11,204 / shares sold: 0 STRONG BUYJun 03 20201 month ago
Hutson Nancy JDirector56,554320,661shares bought: 34,692 / shares sold: 0 STRONG BUYMay 14 20202 months ago
INGRAM ROBERT ADirector65,087369,043shares bought: 74,253 / shares sold: 0 STRONG BUYJun 03 20201 month ago
LEE KENNETH B JRDirector15,25286,479shares bought: 5,000 / shares sold: 0 BUYMay 14 20202 months ago
LEVIN ALAN GDirector00May 14 20202 months ago
Stonehouse Jon PPresident & CEO778,0864,411,748shares bought: 177,376 / shares sold: -71,975 STRONG BUYMay 15 20202 months ago
Thackray Helen M.Director00May 14 20202 months ago

View all BIOCRYST PHARMACEUTICALS INC insiders.

BIOCRYST PHARMACEUTICALS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 03 2020BCRXBIOCRYST PHARMACEU ...HEGGIE THERESADirectorGrantA4.501,1124,99811,20410.1 K to 11.2 K (+11.02 %)
Jun 03 2020BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorGrantA4.504,17118,74965,08760.9 K to 65.1 K (+6.85 %)
May 15 2020BCRXBIOCRYST PHARMACEU ...Stonehouse Jon PPresident & CEOOption ExerciseA3.23157,250507,918157,250
May 14 2020BCRXBIOCRYST PHARMACEU ...Thackray Helen M.DirectorOption ExerciseA5.4140,000216,40040,000
May 14 2020BCRXBIOCRYST PHARMACEU ...LEVIN ALAN GDirectorOption ExerciseA5.4140,000216,40040,000
May 14 2020BCRXBIOCRYST PHARMACEU ...LEE KENNETH B JRDirectorOption ExerciseA5.4140,000216,40040,000
May 14 2020BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorOption ExerciseA5.4140,000216,40040,000
May 14 2020BCRXBIOCRYST PHARMACEU ...Hutson Nancy JDirectorOption ExerciseA5.4140,000216,40040,000
May 14 2020BCRXBIOCRYST PHARMACEU ...HEGGIE THERESADirectorOption ExerciseA5.4140,000216,40040,000
May 14 2020BCRXBIOCRYST PHARMACEU ...ASELAGE STEVEDirectorOption ExerciseA5.4140,000216,40040,000
May 04 2020BCRXBIOCRYST PHARMACEU ...Doyle AnthonyChief Financial Off ...Option ExerciseA3.91600,0002,346,000600,000
Mar 03 2020BCRXBIOCRYST PHARMACEU ...ASELAGE STEVEDirectorGrantA3.001,6664,99825,09223.4 K to 25.1 K (+7.11 %)
Mar 03 2020BCRXBIOCRYST PHARMACEU ...HEGGIE THERESADirectorGrantA3.001,6664,99810,0928.4 K to 10.1 K (+19.77 %)
Mar 03 2020BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorGrantA3.006,25018,75060,91654.7 K to 60.9 K (+11.43 %)
Mar 03 2020BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorGrantA3.006,25018,75060,91654.7 K to 60.9 K (+11.43 %)

View all BIOCRYST PHARMACEUTICALS INC insider transactions.